In his opening presentation at JPM, he highlighted one major product to show how the Irish medtech company is pursuing value-based care.
Medtronic CEO Omar Ishrak has always spoken forcefully about value-based care and his Monday morning presentation at the annual J.P. Morgan Healthcare conference was no different.
In his opening presentation to an investor audience, he highlighted one major product to show how the Irish medtech company is pursuing value-based care. And in a follow-up after the presentation, he described how VBC is the reasonable and logical path forward no matter how chaotic the steps to get there may seem.
